SCHEMBL13348980

SCHEMBL13348980

Cc1ccc(O)c(N=O)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.55
▸ KMT2A Q03164 5/20 0.55
▸ HPGD P15428 4/20 0.55
▸ GRM5 P41594 3/20 0.55
▸ RAB9A P51151 3/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ MAPT P10636 3/20 0.55
▸ HSD17B10 Q99714 2/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ NPC1 O15118 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ TP53 P04637 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ PKM P14618 1/20 0.55
▸ ALOX15 P16050 1/20 0.55
▸ NFKB1 P19838 1/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22315187 0.74 NPC1 (0.31) ALDH1A1KMT2AHPGDGRM5RAB9A
SCHEMBL11301753 0.74 GABRP (0.43) ALDH1A1KMT2AHPGDGRM5RAB9A
SCHEMBL179771 0.71 KMT2A (1.00) ALDH1A1KMT2AHPGDGRM5RAB9A
SCHEMBL179770 0.71 KMT2A (1.00) ALDH1A1KMT2AHPGDGRM5RAB9A
SCHEMBL29766764 0.71 KMT2A (1.00) ALDH1A1KMT2AHPGDGRM5RAB9A
SCHEMBL13348981 0.71 KDM4E (0.38) ALDH1A1KMT2ARAB9AMEN1MAPT
SCHEMBL249139 0.71 — —
SCHEMBL11293274 0.70 MAPT (0.41) ALDH1A1KMT2AHPGDRAB9AMEN1
SCHEMBL1759159 0.70 GRM5 (0.53) ALDH1A1KMT2AHPGDGRM5RAB9A
Methane SCHEMBL6376219 0.69 KDM4E (0.54) ALDH1A1KMT2AHPGDGRM5RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200291034-A1 BRIDGED PIPERIDINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2020-09-17 — — US disclosed
US-7732457-B2 Amino-pyridines as inhibitors of β-secretase WYETH LLC (US) 2010-06-08 — — US disclosed
US-20100113442-A1 TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES FELDING JAKOB 2010-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200291034-A1 BRIDGED PIPERIDINE DERIVATIVES PTGDR, HPGDS, PSEN1 ALDH1A1 2403/4885KMT2A 1094/4885HPGD 113/4885
US-20100113442-A1 TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES PDE5A, PDE3A, PDE3B ALDH1A1 760/4885KMT2A 2349/4885HPGD 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback